id: NDg3OTk4NCA3

reference: 4879984

documentId: 4879984

connectionPointId: 7

lastModificationDate: 1537267566436

stillingsbetegnelse:
Manager of Safety Surveillance Insulin & Devices NGI in Global Safety

jobbeskrivelse:

Do you want to play a key role in the further development of new generation insulin and drive the ongoing safety surveillance activities? And would you like to be part of one of the most skilled and advance safety functions in Denmark? Are setting direction and inspiring a team of highly engaged professionals your key competencies? Then you may be the new manager for the New Generation Insulin (NGI) team.

About the department
Safety Surveillance Insulin & Devices is a department within Global Safety and is situated in Bagsværd, Denmark. We have global responsibility for the surveillance of all safety information for Novo Nordisk’s insulin products and devices that are currently marketed or under development. Within the Safety Surveillance Insulin & Devices department, we have the New Generation Insulin team dedicated to handle all safety surveillance activities for our new generation insulin products Tresiba®, Ryzodeg® and Fiasp®.

The position
You will be responsible for leading a team consisting of 7-10 drug safety/pharmacovigilance experts while ensuring the safety strategy and execution of plans, including safety signal detection and risk management activities pertaining to Tresiba®, Ryzodeg® and Fiasp®.

You will work in a fast-paced environment reflecting the increasing demands from regulatory authorities while always bearing the patient in mind. It will be your job to set direction for your team and to contribute to quality improvement projects.

As such, you will influence the future of Safety Surveillance. Your job responsibilities will also include supervising the internal Novo Nordisk safety committees.

Assuming responsibility, cross-functional collaboration, international communication and taking action will be essential parts of your work day. You will have a close collaboration and interaction with other functional areas in Novo Nordisk, especially the Clinical Development team and Regulatory Affairs team.

Qualifications
Preferably you have a Medical Doctor (MD) degree. Alternatively you may have a university degree within Natural Sciences (DVM, MSc. Pharm. or equivalent). You have a minimum 5 years of experience from the pharmaceutical industry in the medical/clinical development or drug safety departments. A solid understanding of medical concepts, disease processes, scientific methodology, drug development and data analysis is very important, documented scientific training (e.g. PhD) and experience from interactions with regulatory authorities will be an additional advantage.

You will also preferably have successful experience with people management.

You have high personal integrity and are responsible, well-organised, a strong communicator, able to work under pressure when needed and able to make independent decisions regarding drug safety issues.

You are a strong driver and a dedicated team player, who thrives in a global environment of continuous development and you are good at establishing contact and collaborating with stakeholders at all levels.

You must be fluent in English (both written and spoken) and be an experienced user of MS Office (Excel, PowerPoint, Word and Outlook).

Working at Novo Nordisk
At Novo Nordisk, your skills, commitment and ambition help us change lives for diabetes patients for the better. In exchange, we offer you a chance to work with extraordinary talent and to develop both professionally and personally.

Contact
For further information, please contact Wasim Anwar at +45 3079 6766.

Deadline
30 September 2018.

Please note that applications will be reviewed on a continuous basis.

numberOfPosts: 1

jobCategoriesCodes_0: http://data.europa.eu/esco/isco/C2269

abstractJV_contact_0: Please apply using one of the specified channels

positionTypeCode: directhire

contractTypeCodes_0: fulltime

Arbejdsgiver Navn: NOVO NORDISK A/S

source: DK-STAR